A comprehensive population-based study shows that expanded highly active antiretroviral therapy coverage was associated with a 50 percent decrease in new yearly HIV infections among injection drug users.
A comprehensive population-based study shows that expanded highly active antiretroviral therapy coverage was associated with a 50 percent decrease in new yearly HIV infections among injection drug users.